We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$6.73M
Cap. Flow
-$1.03M
Cap. Flow %
-0.79%
Top 10 Hldgs %
28.35%
Holding
135
New
27
Increased
31
Reduced
39
Closed
22

Top Buys

Rank Stock Value
1
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$9.2M
2
ALLK
Allakos
ALLK
+$3.62M
3
TSM icon
TSMC
TSM
+$1.56M
4
LKQ icon
LKQ Corp
LKQ
+$1.2M
5
DBX icon
Dropbox
DBX
+$1M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$2.37M
2
HOLX
Hologic
HOLX
+$1.35M
3
TWTR
Twitter, Inc.
TWTR
+$1.34M
4
BAX icon
Baxter International
BAX
+$1.29M
5
CNC icon
Centene
CNC
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 49.05%
2 Technology 17.83%
3 Communication Services 7.12%
4 Consumer Discretionary 3.23%
5 Financials 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSM icon
26
TSMC
TSM
$2.18T
$1.67M 1.28%
+37,749
New +$1.56M
AERI
27
DELISTED
Aerie Pharmaceuticals
AERI
$1.64M 1.25%
26,564
-8,016
-23% -$515K
PTLA
28
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.63M 1.25%
61,250
-7,558
-11% -$247K
ARNA
29
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.6M 1.22%
34,680
+17,018
+96% +$690K
DVA icon
30
DaVita
DVA
$11.7B
$1.53M 1.17%
21,394
+1,227
+6% +$86.7K
PCRX icon
31
Pacira BioSciences
PCRX
$997M
$1.52M 1.17%
31,033
-7,211
-19% -$312K
APTX
32
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.45M 1.11%
56,270
+1,497
+3% +$36.4K
BSX icon
33
Boston Scientific
BSX
$71.5B
$1.44M 1.1%
37,338
+10,686
+40% +$373K
HCA icon
34
HCA Healthcare
HCA
$89.5B
$1.41M 1.08%
10,163
-317
-3% -$39.5K
PEN icon
35
Penumbra
PEN
$12.8B
$1.39M 1.06%
9,253
+2,173
+31% +$304K
RHT
36
DELISTED
Red Hat Inc
RHT
$1.37M 1.05%
10,080
+6,367
+171% +$911K
MYOK
37
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$1.35M 1.04%
20,758
-1,673
-7% -$98.4K
THC icon
38
Tenet Healthcare
THC
$21.1B
$1.35M 1.03%
47,405
-15,019
-24% -$496K
XYZ
39
Block Inc
XYZ
$47.5B
$1.32M 1.01%
13,336
– –
MOH icon
40
Molina Healthcare
MOH
$10.3B
$1.3M 1%
8,779
+842
+11% +$107K
BPMC
41
DELISTED
Blueprint Medicines
BPMC
$1.21M 0.92%
15,437
+5,648
+58% +$393K
ANAB icon
42
AnaptysBio
ANAB
$1.68B
$1.18M 0.9%
11,823
+10,114
+592% +$839K
PBYI icon
43
Puma Biotechnology
PBYI
$454M
$1.18M 0.9%
25,676
+1,982
+8% +$95.6K
PYPL icon
44
PayPal
PYPL
$50.5B
$1.18M 0.9%
13,404
– –
UNH icon
45
UnitedHealth
UNH
$370B
$1.18M 0.9%
4,420
-1,635
-27% -$425K
LKQ icon
46
LKQ Corp
LKQ
$6.29B
$1.15M 0.88%
+36,219
New +$1.2M
CRUS icon
47
Cirrus Logic
CRUS
$6.26B
$1.14M 0.87%
29,503
+9,588
+48% +$398K
ESPR
48
DELISTED
Esperion Therapeutics
ESPR
$1.13M 0.86%
25,440
-6,808
-21% -$313K
MA icon
49
Mastercard
MA
$493B
$1.09M 0.83%
4,898
+677
+16% +$141K
GWRE icon
50
Guidewire Software
GWRE
$14.2B
$1.08M 0.83%
10,729
+2,638
+33% +$253K
1
2
3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Partner Investment Management held 135 positions worth $131M, up 5.4% from $124M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Partner Investment Management's Q3 2018 filing shows 27 new, 31 increased, 39 reduced and 22 closed positions. Its largest new stake was Allakos: 88,125 shares worth $3.54M. The largest sale was Baidu, an estimated $2.37M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q3 2018 buy was Allakos: 88,125 shares worth $3.54M.
  • Partner Investment Management added most to Neon Therapeutics, Inc. Common Stock in Q3 2018, an estimated $9.2M increase.
  • Partner Investment Management's biggest Q3 2018 reduction was Elevance Health, cutting an estimated $1.02M.
  • Partner Investment Management fully exited Baidu in Q3 2018, selling an estimated $2.37M.
  • Partner Investment Management's ten largest holdings make up 28% of its $131M portfolio in Q3 2018.
  • Partner Investment Management opened 27 new positions and closed 22 in Q3 2018.
  • Partner Investment Management's portfolio value rose 5.4% quarter-over-quarter to $131M.

Based on Partner Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.